VKT Pharma Private Limited — Famotidine Exporter Profile
Indian Pharmaceutical Exporter · #1 for Famotidine · $8.7M export value · DGFT Verified
VKT Pharma Private Limited is the #1 Indian exporter of Famotidine with $8.7M in export value and 173 verified shipments. VKT Pharma Private Limited holds a 15.5% market share in Famotidine exports across 2 countries. The company exports 2 pharmaceutical products worth $8.9M across 1 therapeutic categories.
VKT Pharma Private Limited — Famotidine Export Profile: Buyers & Destinations
Where Does VKT Pharma Private Limited Export Famotidine?
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $5.9M | 162 | 97.2% |
| UNITED STATES OF AMERICA | $100.0K | 2 | 1.7% |
| CANADA | $69.4K | 9 | 1.1% |
VKT Pharma Private Limited exports Famotidine to 3 countries. The largest destination is UNITED STATES accounting for 97.2% of VKT Pharma Private Limited's Famotidine shipments, followed by UNITED STATES OF AMERICA (1.7%) and CANADA (1.1%). These destinations reflect VKT Pharma Private Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Famotidine from VKT Pharma Private Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| TO THE ORDER | UNITED STATES | $1.2M | 38 |
| M S ASCEND LABORATORIES LLC | UNITED STATES | $1.1M | 25 |
| TO THE ORDER, | UNITED STATES | $657.6K | 17 |
| TO THE ORDER.., | UNITED STATES | $617.7K | 14 |
| GLENMARK THERAPEUTICS INC., USA | UNITED STATES | $496.5K | 18 |
| M/S ASCEND LABORATORIES, LLC. | UNITED STATES | $378.2K | 9 |
| GLENMARK THERAPEUTICS INC USA | UNITED STATES | $330.9K | 12 |
| ASCEND LABORATORIES LLC | UNITED STATES | $316.8K | 8 |
| GRANULES USA INC | UNITED STATES | $274.0K | 8 |
| GLENMARK THERAPEUTICS INC. USA | UNITED STATES | $130.6K | 6 |
VKT Pharma Private Limited supplies Famotidine to 18 buyers globally. The largest buyer is TO THE ORDER (UNITED STATES), followed by M S ASCEND LABORATORIES LLC (UNITED STATES) and TO THE ORDER, (UNITED STATES). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Famotidine Export Value and How Much Does VKT Pharma Private Limited Contribute?
India exported $40.4M worth of Famotidine through 2,750 shipments from 152 suppliers to 66 countries, serving 302 buyers globally. VKT Pharma Private Limited contributes $8.7M to this total, accounting for 15.5% of India's Famotidine exports. VKT Pharma Private Limited ships Famotidine to 3 countries through 18 buyers.
What Is the Average Shipment Value for VKT Pharma Private Limited's Famotidine Exports?
VKT Pharma Private Limited's average Famotidine shipment value is $50.0K per consignment, based on 173 shipments totaling $8.7M. The largest destination is UNITED STATES (97.2% of VKT Pharma Private Limited's Famotidine exports).
How Does VKT Pharma Private Limited Compare to Other Indian Famotidine Exporters?
VKT Pharma Private Limited ranks #1 among 152 Indian Famotidine exporters with a 15.5% market share. The top 3 exporters are VKT PHARMA PRIVATE LIMITED ($8.7M), ANNORA PHARMA PRIVATE LIMITED ($8.1M), MYLAN LABORATORIES LIMITED ($7.5M). VKT Pharma Private Limited processed 173 shipments to 2 destination countries.
What Famotidine Formulations Does VKT Pharma Private Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| FAMOTIDINE TABLETS, USP 40 MG ( INV. QTY | $268.9K | 7 |
| FAMOTIDINE TABLETS USP 20MGNDC NO:67877-842-01QTY:102605X100=10260500 NOS | $150.0K | 3 |
| FAMOTIDINE TABLETS, USP 20MG , NDC NO: 72657011320 (INV.QTY: 51303X200 = 10260600 NO'S) UNIT SIZE: 200'S | $120.1K | 3 |
| FAMOTIDINE TABLETS USP 20MG NDC NO. 7265 | $108.8K | 4 |
| FAMOTIDINE TABLETS, USP 20mg, NDC NO:72657011320 (INV.QTY:123432X200=24686400 No's) UNIT SIZE: 200's,B/N.FA2024056D, FA2 | $100.0K | 2 |
| FAMOTIDINE TABLETS USP 20mg NDC NO 72657011320 INV QTY 25608X200 5121600 No s UNIT SIZE 200 s B N FA2025024A | $100.0K | 2 |
| FAMOTIDINE TABLETS USP 40mg NDC No 67877 889 05 | $99.1K | 3 |
| FAMOTIDINE TABLETS USP 40MGNDC NO:67877-843-01QTY:3263X100=3263100 NOS | $81.4K | 2 |
| FAMOTIDINE TABLETS USP 20mg NDC No 67877 842 10 | $81.2K | 2 |
| FAMOTIDINE TABLETS USP 40 MG NDC NO. | $78.7K | 3 |
VKT Pharma Private Limited exports 133 distinct Famotidine formulations including tablets, capsules, syrups, and combination drugs. The top formulation is FAMOTIDINE TABLETS, USP 40 MG ( INV. QTY with 7 shipments worth $268.9K.
Regulatory Requirements: Exporting Famotidine to Key Markets
What VKT Pharma Private Limited must comply with to export Famotidine to its top destination countries
United States — FDA
Approval Process
ANDA (Abbreviated New Drug Application) for generics. Indian manufacturing site must pass FDA pre-approval inspection. Drug Master File (DMF) required for APIs.
Timeline: 10–18 months for ANDA approval
GMP & Export Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA
Drug Listing with FDA; Export Certificate from CDSCO India; Import Alert screening via FDA PREDICT system
Note: Subject to FDA Import Alerts. Open Form 483 observations can block all exports from a facility.
Canada — HC
Approval Process
ANDS (Abbreviated New Drug Submission) referencing Canadian Reference Product. Comparative bioavailability study required.
Timeline: 12–18 months
GMP & Export Requirements
Health Canada GMP (GUI-0001); Drug Establishment Licence (DEL) inspection
Drug Identification Number (DIN) for each product; Certificate of Pharmaceutical Product from CDSCO
Note: Subject to Good Import Practices and annual C.01.014.6 review.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does VKT Pharma Private Limited Compare to Nearest Famotidine Exporters?
Exporters ranked immediately above and below #1 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 1 | VKT PHARMA PRIVATE LIMITED ★ | $8.7M | 173 | 2 | $50.0K |
| 2 | ANNORA PHARMA PRIVATE LIMITED | $8.1M | 435 | 3 | $18.6K |
| 3 | MYLAN LABORATORIES LIMITED | $7.5M | 212 | 2 | $35.6K |
VKT Pharma Private Limited ranks #1 among 152 Indian Famotidine exporters. Average shipment value of $50.0K compared to the market average of $265.7K. The closest competitors by value are ANNORA PHARMA PRIVATE LIMITED and MYLAN LABORATORIES LIMITED.
Which Indian Ports Ship Famotidine Exports?
| Port | Shipments | % Share |
|---|---|---|
| DELHI AIR CARGO ACC (INDEL4) | 264 | 9.6% |
| HYDERABAD ICD | 251 | 9.1% |
| SAHAR AIR | 239 | 8.7% |
| DELHI AIR | 188 | 6.8% |
| NHAVA SHEVA SEA (INNSA1) | 163 | 5.9% |
| SAHAR AIR CARGO ACC (INBOM4) | 155 | 5.6% |
| HYDERABAD ICD (INSNF6) | 153 | 5.6% |
| HYDERABAD AIR | 86 | 3.1% |
What Other Gastrointestinal Products Does VKT Pharma Private Limited Export?
VKT Pharma Private Limited also exports these gastrointestinal products. Each links to the detailed product page.
Geopolitical & Trade Policy Impact on VKT Pharma Private Limited's Famotidine Exports
The current geopolitical climate presents both challenges and opportunities for Indian pharmaceutical exporters like VKT Pharma. The Israel-Iran conflict has disrupted key shipping routes in the Red Sea, leading to increased freight costs and extended transit times. These disruptions have particularly impacted exports to the West Asia and North Africa (WANA) region, which accounted for $1.75 billion of India's pharmaceutical exports in FY25. (pharmaceuticalcommerce.com) For VKT Pharma, which relies on timely deliveries, these logistical challenges necessitate strategic adjustments, such as exploring alternative shipping routes or increasing buffer inventories.
Conversely, the U.S.-China trade tensions have opened avenues for Indian pharmaceutical companies to capture a larger share of the U.S. market. India's pharmaceutical exports to the U.S. surged by 20.4% in FY25, reaching $10.5 billion. (business-standard.com) VKT Pharma's recent FDA approval for Ranitidine positions it well to capitalize on this trend. However, potential U.S. tariffs on pharmaceutical imports could pose risks, underscoring the importance of market diversification. The recent India–European Union Free Trade Agreement, signed in January 2026, eliminates tariffs on pharmaceuticals, providing an opportunity for VKT Pharma to expand its presence in the European market. (en.wikipedia.org)
VKT Pharma Private Limited — Regulatory Compliance & Quality Standards
India has made significant strides in regulatory compliance, surpassing the U.S. in the number of FDA-registered generic manufacturing sites, with 752 FDA-approved facilities as of 2024. (business-standard.com) VKT Pharma's recent FDA approval for Ranitidine underscores its adherence to stringent quality standards. However, the industry faces challenges related to quality compliance, as evidenced by instances of contaminated products. (economictimes.indiatimes.com) Maintaining rigorous quality control measures is imperative for VKT Pharma to sustain its market position and meet evolving global standards.
About VKT Pharma Private Limited
VKT Pharma Private Limited exports 2 products worth $8.9M. Beyond Famotidine, top products include Ranitidine. View the complete VKT Pharma Private Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Famotidine — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Famotidine shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: VKT Pharma Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 173 individual customs records matching VKT Pharma Private Limited exporting Famotidine, covering 133 formulations to 3 countries via 18 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 66+ countries, 302+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Famotidine Export Data from VKT Pharma Private Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for VKT Pharma Private Limited's Famotidine exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
VKT Pharma Private Limited
Full Company Profile →
2 products · $8.9M total trade · 1 categories
Famotidine Stats
Company Overview
Top Products by VKT Pharma Private Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for VKT Pharma Private Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Famotidine. For current shipment-level data, contact TransData Nexus.